Home › Companies › IONIS PHARMACEUTICALS INC. › 2024-2025
Compiled from SEC Form N-PX filings and IONIS PHARMACEUTICALS INC.’s Form 8-K, filed 2025-06-10 (Item 5.07 on EDGAR). Page generated 04 October 2026.
Explore IONIS PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are IONIS PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-10 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Allene M. Diaz | 134,533,610 | 3,812,549 | 64,043 | -- | 10,701,820 | Majority: yes |
| Elect Director: Michael Hayden | 133,250,556 | 5,107,295 | 52,351 | -- | 10,701,820 | Majority: yes |
| Elect Director: Joseph Klein, III | 127,135,692 | 11,224,182 | 50,328 | -- | 10,701,820 | Majority: yes |
| Elect Director: Joseph Loscalzo | 108,835,662 | 29,465,062 | 109,478 | -- | 10,701,820 | Majority: yes |
| Proposal 2: An advisory vote on the compensation paid to the Company's executive officers, including the following resolution: "RESOLVED, that Ionis' stockholders approve, on an advisory (nonbinding) basis, the compensation of the named executive officers, as | 132,567,606 | 5,738,006 | 104,590 | -- | 10,701,820 | Passed |
| Proposal 3: Approval of an amendment of the Ionis Pharmaceuticals, Inc | 108,160,711 | 30,105,665 | 143,826 | -- | 10,701,820 | Passed |
| Proposal 4: Ratify the Audit Committee's selection of Ernst & Young LLP as independent auditors for the 2025 fiscal year: | 144,587,537 | 4,426,728 | 97,757 | -- | 0 | Passed |
Source: IONIS PHARMACEUTICALS INC., Form 8-K, filed with the SEC on 2025-06-10 — read the filing on EDGAR.
Each item below shows how the 376 asset managers that disclosed a IONIS PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of IONIS PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held 2025-06-05.
Combines 9 wordings of this item as funds reported it.
96% Passed · of votes cast
IONIS PHARMACEUTICALS INC.’s own tally for this item (“Proposal 2: An advisory vote on the compensation paid to the Company's executive officers, including the following resolution: "RESOLVED, that Ionis' stockholders approve, on an advisory (nonbinding) basis, the compensat”): 132,567,606 for, 5,738,006 against — passed, per its Form 8-K filed 2025-06-10 (Item 5.07). Of all 159,041,259 outstanding shares: 83% for, 4% against (87% of the company cast a for/against vote).
The 370 asset managers below cast 97% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 37,693,016 | 0 | 0 | 0 | For |
| T. Rowe Price | 30,383,467 | 0 | 0 | 0 | For |
| Vanguard | 23,387,266 | 2,933 | 0 | 0 | For |
| Capital Group | 20,941,240 | 0 | 0 | 0 | For |
| Wellington | 8,107,185 | 0 | 0 | 0 | For |
| BlackRock | 6,529,254 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 4,933,784 | 0 | 0 | 0 | For |
| State Street | 4,416,143 | 2,548 | 0 | 0 | For |
| NEW ECONOMY FUND | 3,221,927 | 0 | 0 | 0 | For |
| Tweedy, Browne Co LLC | 2,865,613 | 0 | 0 | 0 | For |
| Charles Schwab | 2,864,156 | 0 | 0 | 0 | For |
| TWEEDY, BROWNE FUND INC. | 2,656,669 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 2,540,136 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,969,221 | 0 | 0 | 0 | For |
| BVF INC/IL | 1,913,385 | 0 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 1,597,189 | 0 | 0 | 0 | For |
| Invesco | 1,348,054 | 0 | 0 | 0 | For |
| BNP Paribas Asset Management Holding S.A. | 0 | 1,203,742 | 0 | 0 | Against |
| Waddell & Reed | 1,171,253 | 0 | 0 | 0 | For |
| Jackson National | 1,070,813 | 0 | 0 | 0 | For |
| ARK ETF Trust | 1,004,369 | 0 | 0 | 0 | For |
| Aberdeen | 839,033 | 0 | 0 | 0 | For |
| Candriam S.C.A. | 0 | 820,451 | 0 | 0 | Against |
| Camber Capital Management LP | 725,000 | 0 | 0 | 0 | For |
| MassMutual | 691,743 | 0 | 0 | 0 | For |
Showing the 25 largest of 370 asset managers. See all 370 in the interactive database.
Meeting held 2025-06-05.
Combines 4 wordings of this item as funds reported it.
97% Passed · of votes cast
IONIS PHARMACEUTICALS INC.’s own tally for this item (“Proposal 4: Ratify the Audit Committee's selection of Ernst & Young LLP as independent auditors for the 2025 fiscal year:”): 144,587,537 for, 4,426,728 against — passed, per its Form 8-K filed 2025-06-10 (Item 5.07). Of all 159,041,259 outstanding shares: 91% for, 3% against (94% of the company cast a for/against vote).
The 80 asset managers below cast 99.4% of the shares they voted on this item FOR (76,320,257 for, 416,986 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 22,955,139 | 2,519 | 0 | 0 | For |
| Fidelity | 14,514,323 | 0 | 0 | 0 | For |
| T. Rowe Price | 11,535,490 | 0 | 0 | 0 | For |
| Capital Group | 8,567,278 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 3,221,927 | 0 | 0 | 0 | For |
| TWEEDY, BROWNE FUND INC. | 2,656,669 | 0 | 0 | 0 | For |
| BlackRock | 2,650,399 | 0 | 0 | 0 | For |
| Charles Schwab | 1,416,625 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,165,423 | 0 | 0 | 0 | For |
| State Street | 1,123,205 | 43 | 0 | 0 | For |
| Jackson National | 1,070,813 | 0 | 0 | 0 | For |
| ARK ETF Trust | 1,004,369 | 0 | 0 | 0 | For |
| MassMutual | 691,480 | 0 | 0 | 0 | For |
| Invesco | 625,827 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 392,836 | 0 | 0 | Against |
| Empower | 378,121 | 0 | 0 | 0 | For |
| Goldman Sachs | 342,175 | 0 | 0 | 0 | For |
| TIAA | 273,758 | 0 | 0 | 0 | For |
| Pacific Life | 235,477 | 0 | 0 | 0 | For |
| Brighthouse | 209,012 | 0 | 6,470 | 0 | For |
| John Hancock | 153,386 | 0 | 0 | 0 | For |
| Artisan | 138,097 | 0 | 0 | 0 | For |
| Hartford | 116,932 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 113,548 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 109,589 | 0 | 0 | 0 | For |
Showing the 25 largest of 80 asset managers. See all 80 in the interactive database.
Meeting held 2025-06-05.
Combines 2 wordings of this item as funds reported it.
78% Passed · of votes cast
IONIS PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: Approval of an amendment of the Ionis Pharmaceuticals, Inc”): 108,160,711 for, 30,105,665 against — passed, per its Form 8-K filed 2025-06-10 (Item 5.07). Of all 159,041,259 outstanding shares: 68% for, 19% against (87% of the company cast a for/against vote).
The 79 asset managers below cast 80% of the shares they voted on this item FOR (61,670,833 for, 15,022,346 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 22,957,652 | 6 | 0 | 0 | For |
| Fidelity | 2,217,684 | 12,296,639 | 0 | 0 | Against |
| T. Rowe Price | 11,535,490 | 0 | 0 | 0 | For |
| Capital Group | 8,567,278 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 3,221,927 | 0 | 0 | 0 | For |
| TWEEDY, BROWNE FUND INC. | 0 | 2,656,669 | 0 | 0 | Against |
| BlackRock | 2,650,399 | 0 | 0 | 0 | For |
| Charles Schwab | 1,416,625 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,165,423 | 0 | 0 | 0 | For |
| State Street | 1,123,237 | 11 | 0 | 0 | For |
| Jackson National | 1,070,813 | 0 | 0 | 0 | For |
| ARK ETF Trust | 1,004,369 | 0 | 0 | 0 | For |
| MassMutual | 691,480 | 0 | 0 | 0 | For |
| Invesco | 625,827 | 0 | 0 | 0 | For |
| Aberdeen | 392,836 | 0 | 0 | 0 | For |
| Empower | 378,121 | 0 | 0 | 0 | For |
| Goldman Sachs | 342,175 | 0 | 0 | 0 | For |
| TIAA | 273,758 | 0 | 0 | 0 | For |
| Pacific Life | 235,477 | 0 | 0 | 0 | For |
| Brighthouse | 209,012 | 0 | 6,470 | 0 | For |
| John Hancock | 153,386 | 0 | 0 | 0 | For |
| Artisan | 138,097 | 0 | 0 | 0 | For |
| Hartford | 116,932 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 113,548 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 109,589 | 0 | 0 | 0 | For |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Meeting held 2025-06-05.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
IONIS PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Allene M. Diaz”): 134,533,610 for, 3,812,549 against, per its Form 8-K filed 2025-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 159,041,259 outstanding shares: 85% for, 2% against (87% of the company cast a for/against vote).
The 78 asset managers below cast 97% of the shares they voted on this item FOR (74,242,946 for, 2,494,224 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 22,957,657 | 1 | 0 | 0 | For |
| Fidelity | 14,514,323 | 0 | 0 | 0 | For |
| T. Rowe Price | 9,185,557 | 2,349,933 | 0 | 0 | For |
| Capital Group | 8,567,278 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 3,221,927 | 0 | 0 | 0 | For |
| TWEEDY, BROWNE FUND INC. | 2,656,669 | 0 | 0 | 0 | For |
| BlackRock | 2,650,399 | 0 | 0 | 0 | For |
| Charles Schwab | 1,416,625 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,165,423 | 0 | 0 | 0 | For |
| State Street | 1,123,248 | 0 | 0 | 0 | For |
| Jackson National | 1,070,813 | 0 | 0 | 0 | For |
| ARK ETF Trust | 1,004,369 | 0 | 0 | 0 | For |
| MassMutual | 690,144 | 1,336 | 0 | 0 | For |
| Invesco | 625,827 | 0 | 0 | 0 | For |
| Aberdeen | 392,836 | 0 | 0 | 0 | For |
| Empower | 378,121 | 0 | 0 | 0 | For |
| Goldman Sachs | 342,175 | 0 | 0 | 0 | For |
| TIAA | 273,758 | 0 | 0 | 0 | For |
| Pacific Life | 235,477 | 0 | 0 | 0 | For |
| Brighthouse | 134,206 | 74,806 | 6,470 | 0 | For |
| John Hancock | 140,719 | 12,667 | 0 | 0 | For |
| Artisan | 138,097 | 0 | 0 | 0 | For |
| Hartford | 116,932 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 113,548 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 109,589 | 0 | 0 | 0 | For |
Showing the 25 largest of 78 asset managers. See all 78 in the interactive database.
Meeting held 2025-06-05.
Combines 4 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
IONIS PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Joseph Klein, III”): 127,135,692 for, 11,224,182 against, per its Form 8-K filed 2025-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 159,041,259 outstanding shares: 80% for, 7% against (87% of the company cast a for/against vote).
The 78 asset managers below cast 95% of the shares they voted on this item FOR (72,632,027 for, 4,105,143 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 22,957,656 | 2 | 0 | 0 | For |
| Fidelity | 14,514,323 | 0 | 0 | 0 | For |
| T. Rowe Price | 9,185,557 | 2,349,933 | 0 | 0 | For |
| Capital Group | 8,567,278 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 3,221,927 | 0 | 0 | 0 | For |
| TWEEDY, BROWNE FUND INC. | 2,656,669 | 0 | 0 | 0 | For |
| BlackRock | 2,650,399 | 0 | 0 | 0 | For |
| Charles Schwab | 1,416,625 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,165,423 | 0 | 0 | 0 | For |
| State Street | 3,811 | 1,119,437 | 0 | 0 | Against |
| Jackson National | 1,070,813 | 0 | 0 | 0 | For |
| ARK ETF Trust | 1,004,369 | 0 | 0 | 0 | For |
| MassMutual | 690,144 | 1,336 | 0 | 0 | For |
| Invesco | 625,827 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 392,836 | 0 | 0 | Against |
| Empower | 378,121 | 0 | 0 | 0 | For |
| Goldman Sachs | 342,175 | 0 | 0 | 0 | For |
| TIAA | 273,758 | 0 | 0 | 0 | For |
| Pacific Life | 235,477 | 0 | 0 | 0 | For |
| Brighthouse | 134,206 | 74,806 | 6,470 | 0 | For |
| John Hancock | 140,719 | 12,667 | 0 | 0 | For |
| Artisan | 138,097 | 0 | 0 | 0 | For |
| Hartford | 116,932 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 113,548 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 40,729 | 68,860 | 0 | 0 | Against |
Showing the 25 largest of 78 asset managers. See all 78 in the interactive database.
Meeting held 2025-06-05.
Combines 3 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
IONIS PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Joseph Loscalzo”): 108,835,662 for, 29,465,062 against, per its Form 8-K filed 2025-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 159,041,259 outstanding shares: 68% for, 19% against (87% of the company cast a for/against vote).
The 78 asset managers below cast 79% of the shares they voted on this item FOR (60,359,776 for, 16,377,393 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 22,955,133 | 2,525 | 0 | 0 | For |
| Fidelity | 14,514,323 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 11,535,490 | 0 | 0 | Against |
| Capital Group | 8,567,278 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 3,221,927 | 0 | 0 | 0 | For |
| TWEEDY, BROWNE FUND INC. | 2,656,669 | 0 | 0 | 0 | For |
| BlackRock | 2,650,399 | 0 | 0 | 0 | For |
| Charles Schwab | 1,416,625 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,165,423 | 0 | 0 | 0 | For |
| State Street | 3,811 | 1,119,437 | 0 | 0 | Against |
| Jackson National | 0 | 1,070,813 | 0 | 0 | Against |
| ARK ETF Trust | 1,004,369 | 0 | 0 | 0 | For |
| MassMutual | 0 | 691,480 | 0 | 0 | Against |
| Invesco | 0 | 625,827 | 0 | 0 | Against |
| Aberdeen | 392,836 | 0 | 0 | 0 | For |
| Empower | 0 | 378,121 | 0 | 0 | Against |
| Goldman Sachs | 0 | 342,175 | 0 | 0 | Against |
| TIAA | 273,758 | 0 | 0 | 0 | For |
| Pacific Life | 235,477 | 0 | 0 | 0 | For |
| Brighthouse | 2,657 | 206,355 | 6,470 | 0 | Against |
| John Hancock | 129,895 | 23,491 | 0 | 0 | For |
| Artisan | 138,097 | 0 | 0 | 0 | For |
| Hartford | 116,932 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 113,548 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 40,729 | 68,860 | 0 | 0 | Against |
Showing the 25 largest of 78 asset managers. See all 78 in the interactive database.
Meeting held 2025-06-05.
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
IONIS PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Michael Hayden”): 133,250,556 for, 5,107,295 against, per its Form 8-K filed 2025-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 159,041,259 outstanding shares: 84% for, 3% against (87% of the company cast a for/against vote).
The 78 asset managers below cast 97% of the shares they voted on this item FOR (74,242,942 for, 2,494,228 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 22,957,657 | 1 | 0 | 0 | For |
| Fidelity | 14,514,323 | 0 | 0 | 0 | For |
| T. Rowe Price | 9,185,557 | 2,349,933 | 0 | 0 | For |
| Capital Group | 8,567,278 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 3,221,927 | 0 | 0 | 0 | For |
| TWEEDY, BROWNE FUND INC. | 2,656,669 | 0 | 0 | 0 | For |
| BlackRock | 2,650,399 | 0 | 0 | 0 | For |
| Charles Schwab | 1,416,625 | 0 | 0 | 0 | For |
| Waddell & Reed | 1,165,423 | 0 | 0 | 0 | For |
| State Street | 1,123,248 | 0 | 0 | 0 | For |
| Jackson National | 1,070,813 | 0 | 0 | 0 | For |
| ARK ETF Trust | 1,004,369 | 0 | 0 | 0 | For |
| MassMutual | 690,144 | 1,336 | 0 | 0 | For |
| Invesco | 625,827 | 0 | 0 | 0 | For |
| Aberdeen | 392,836 | 0 | 0 | 0 | For |
| Empower | 378,121 | 0 | 0 | 0 | For |
| Goldman Sachs | 342,175 | 0 | 0 | 0 | For |
| TIAA | 273,758 | 0 | 0 | 0 | For |
| Pacific Life | 235,477 | 0 | 0 | 0 | For |
| Brighthouse | 134,206 | 74,806 | 6,470 | 0 | For |
| John Hancock | 140,719 | 12,667 | 0 | 0 | For |
| Artisan | 138,097 | 0 | 0 | 0 | For |
| Hartford | 116,932 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 113,548 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 109,589 | 0 | 0 | 0 | For |
Showing the 25 largest of 78 asset managers. See all 78 in the interactive database.
Meeting held 2025-06-05.
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 4 asset managers below cast 100% of the shares they voted on this item FOR (482,311 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Eversept Partners, LP | 426,630 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 51,300 | 0 | 0 | 0 | For |
| Maj Invest Holding A/S | 4,281 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 100 | 0 | 0 | 0 | For |
Meeting held 2025-06-05.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR (73 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Simplify Exchange Traded Funds | 63 | 0 | 0 | 0 | For |
| VOISARD ASSET MANAGEMENT GROUP, INC. | 10 | 0 | 0 | 0 | For |
Meeting held 2025-06-05.
All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Simplify Exchange Traded Funds | 63 | 0 | 0 | 0 | For |
| VOISARD ASSET MANAGEMENT GROUP, INC. | 10 | 0 | 0 | 0 | For |
Meeting held 2024-06-06 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
97% Passed · of votes cast
IONIS PHARMACEUTICALS INC.’s own tally for this item (“Proposal 2: An advisory vote on the compensation paid to the Company's executive officers, including the following resolution: "RESOLVED, that Ionis' stockholders approve, on an advisory (nonbinding) basis, the compensat”): 118,899,475 for, 4,228,901 against — passed, per its Form 8-K filed 2024-06-10 (Item 5.07). Of all 159,041,259 outstanding shares: 75% for, 3% against (77% of the company cast a for/against vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (2,032 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| COLDSTREAM CAPITAL MANAGEMENT INC | 2,032 | 0 | 0 | 0 | For |
| Echo45 Advisors LLC | 0 | 0 | 0 | 0 | -- |
Ranked by the number of IONIS PHARMACEUTICALS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 159,041,259 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 23.70% |
| 2 | T. Rowe Price | 19.10% |
| 3 | Vanguard | 14.71% |
| 4 | Capital Group | 13.17% |
| 5 | Wellington | 5.10% |
| 6 | BlackRock | 4.11% |
| 7 | Deep Track Capital, LP | 3.10% |
| 8 | State Street | 2.78% |
| 9 | NEW ECONOMY FUND | 2.03% |
| 10 | Tweedy, Browne Co LLC | 1.80% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| FMR (Fidelity) | 14.85% | 13F |
| FMR LLC | 13.53% | DEF14A |
| Capital World Investors | 13.32% | 13G |
| Vanguard Group | 10.30% | 13F |
| BlackRock | 7.08% | 13F |
| BlackRock Institutional Trust Company, N.A | 5.69% | DEF14A |
| Wellington Management | 5.29% | 13F |
| State Street | 3.05% | 13F |
| Citadel Advisors | 2.27% | 13F |
| T. Rowe Price | 2.05% | 13F |
Percentages above are of 159,041,259 shares outstanding, as reported by IONIS PHARMACEUTICALS INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from IONIS PHARMACEUTICALS INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.
At IONIS PHARMACEUTICALS INC.'s shareholder meeting held 2025-06-05, in the 2024-2025 proxy season, 376 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,513 separate fund positions. Their filings are grouped here into 11 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To make an advisory vote on executive compensation. — the proposal passed with 96% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: IONIS PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-10.
IONIS PHARMACEUTICALS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.